ERBB2 and breast cancer: BRCA1-associated breast cancers have a characteristic phenotype; in general, these tumors have a high mitotic index, contain p53 mutations, and often exhibit a triple-negative phenotype (i.e. lack of expression of estrogen and progesterone receptors and lack of overexpression of the HER2/NEU oncogene) [8,9].